Up next

Autoplay

Molecular Testing in Thyroid Cancer

0 Views • 07/01/23
Share
Embed
administrator
administrator
Subscribers
0

Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay